Journal of Cardiovascular Development and Disease (Apr 2024)

How Artificial Intelligence Can Enhance the Diagnosis of Cardiac Amyloidosis: A Review of Recent Advances and Challenges

  • Moaz A. Kamel,
  • Mohammed Tiseer Abbas,
  • Christopher N. Kanaan,
  • Kamal A. Awad,
  • Nima Baba Ali,
  • Isabel G. Scalia,
  • Juan M. Farina,
  • Milagros Pereyra,
  • Ahmed K. Mahmoud,
  • D. Eric Steidley,
  • Julie L. Rosenthal,
  • Chadi Ayoub,
  • Reza Arsanjani

DOI
https://doi.org/10.3390/jcdd11040118
Journal volume & issue
Vol. 11, no. 4
p. 118

Abstract

Read online

Cardiac amyloidosis (CA) is an underdiagnosed form of infiltrative cardiomyopathy caused by abnormal amyloid fibrils deposited extracellularly in the myocardium and cardiac structures. There can be high variability in its clinical manifestations, and diagnosing CA requires expertise and often thorough evaluation; as such, the diagnosis of CA can be challenging and is often delayed. The application of artificial intelligence (AI) to different diagnostic modalities is rapidly expanding and transforming cardiovascular medicine. Advanced AI methods such as deep-learning convolutional neural networks (CNNs) may enhance the diagnostic process for CA by identifying patients at higher risk and potentially expediting the diagnosis of CA. In this review, we summarize the current state of AI applications to different diagnostic modalities used for the evaluation of CA, including their diagnostic and prognostic potential, and current challenges and limitations.

Keywords